Apr 19, 2023 / 04:45PM GMT
Serge Belanger - Needham & Company, LLC - Analyst
Hi, good afternoon. I'm Serge Belanger, one of the senior healthcare analysts at Needham. I want to welcome you to our 22nd Annual Healthcare Conference. For our next session, we have the team from Amphastar Pharmaceuticals with us. We have Bill Peters, the CFO; Dan Dischner, VP, Corporate Communications; and Jacob Liawatidewi from Corporate Administration.
So I'll hand it over to the Amphastar team. They'll give us a quick overview of the company, then we'll move to questions. (Operator Instructions) So I'll hand it over to the Amphastar team.
Dan Dischner - Amphastar Pharmaceuticals, Inc. - Senior VP of Human Resource and Corporate Communications
Thanks, Serge, we're really happy to be here today. As you know, Amphastar is a fully integrated biopharmaceutical company. And when we say fully integrated, to that -- to us, it means that we develop our own products. We manufacture API and key components. We make all our finished products in the United States with a complete front-end integration,
Amphastar Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot